Document is current
Any future updates will be listed below
-
Authors
Bichakjian, Chris K.
Swetter, Susan M.
Carroll, Bryan T.
Vidal, Nahid Y.
Simons, Evan A.
Vetto, John T.
Yu, Wesley Y.
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct06673095 at ClinicalTrials.govDocuments that mention this clinical trial
ICEMAN (Intelligent Choice of Excision Margin): A Randomized Controlled Trial of Adaptive Narrow Excision Versus Wide Excision for Adults with AJCC Stage I Cutaneous Melanoma
https://doi.org/10.1245/s10434-025-18282-w
-
Funding
Funding for this research was provided by:
VA Career Development Award (1IK2CX002642-01A1)
US Department of Defense CDMRP Award (W81XWH-21-1-0818)
- License Information
-
More Information
Article History
Received: 21 May 2025
Accepted: 19 August 2025
First Online: 8 September 2025
Disclosure
: WY has received research support from SkylineDx and has served as a scientific advisor to Castle Biosciences. WY is supported by a VA Career Development Award (1IK2CX002642-01A1), a US Department of Defense CDMRP Award (W81XWH-21-1-0818), a Kuni Foundation Cancer Discovery Grant, and a Kuni Foundation Cancer Research Fellows Award. JV is a speaker for Castle Biosciences.
